Jonathan A. Tobert
- Surgery top 1%
- Lipoproteins and Cardiovascular Health 30
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Biotechnology top 1%
- Microbial Metabolism and Applications 8
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 6
- Pharmacology top 1%
-
- Health Systems, Economic Evaluations, Quality of Life 9
- Pharmaceutical Economics and Policy 5
-
- Plant biochemistry and biosynthesis 5
-
- Computational Drug Discovery Methods 4
- Co-authors
- Terje R. PedersenConnie B. NewmanJohn KjekshusTorben HaghfeltAnders OlssonThomas J. CookKalevi PyörälàDavid Preiss
- Journals
- The American Journal of Cardiology (6 papers)Clinical Pharmacology & Therapeutics (4 papers)Circulation (3 papers)
- Partner nations
- United StatesUnited KingdomNorway
In The Last Decade
Jonathan A. Tobert
50 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Surgery 2.7k
- Endocrinology, Diabetes and Metabolism 988
- Biotechnology 396
- Cancer Research 556
- Pharmacology 294
Countries citing papers authored by Jonathan A. Tobert
This map shows the geographic impact of Jonathan A. Tobert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan A. Tobert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan A. Tobert more than expected).
Fields of papers citing papers by Jonathan A. Tobert
This network shows the impact of papers produced by Jonathan A. Tobert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan A. Tobert. The network helps show where Jonathan A. Tobert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jonathan A. Tobert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 9 | |
| 2 | 2022 | 4 | |
| 3 | 2020 | 47 | |
| 4 | Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Associationbreakdown → | 2019 | 488 |
| 5 | 2004 | 31 | |
| 6 | 2004 | 107 | |
| 7 | Lovastatin and beyond: the history of the HMG-CoA reductase inhibitorsbreakdown → | 2003 | 637 |
| 8 | 1999 | 112 | |
| 9 | 1998 | 328 | |
| 10 | 1998 | 478 | |
| 11 | 1997 | 146 | |
| 12 | 1996 | 15 | |
| 13 | 1989 | 1 | |
| 14 | 1988 | 281 | |
| 15 | 1987 | 22 | |
| 16 | 1987 | 168 | |
| 17 | 1981 | 53 | |
| 18 | 1977 | 3 | |
| 19 | 1976 | 42 | |
| 20 | 1975 | 6 |
About Jonathan A. Tobert
Jonathan A. Tobert is a scholar working on Biotechnology, Surgery, Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Cancer Research, having authored 50 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (30 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Microbial Metabolism and Applications (8 papers), Cancer, Lipids, and Metabolism (6 papers), Plant biochemistry and biosynthesis (5 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Pharmaceutical Economics and Policy (5 papers) and Computational Drug Discovery Methods (4 papers). The work is most often cited by research in Surgery (2.7k citations), Endocrinology, Diabetes and Metabolism (988 citations), Biotechnology (396 citations), Cancer Research (556 citations) and Pharmacology (294 citations). Jonathan A. Tobert has collaborated with scholars based in United States, United Kingdom and Norway. Frequent co-authors include Terje R. Pedersen, Connie B. Newman, John Kjekshus, Torben Haghfelt, Anders Olsson, Thomas J. Cook, Kalevi Pyörälà, David Preiss, Michele Mercuri and Ian Holmes. Their work appears in journals such as The American Journal of Cardiology, Clinical Pharmacology & Therapeutics, Circulation, JAMA and Reproduction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.